Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | TOP1 | P11387 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.33 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2728461 | 0.95 | CYP1A1 (0.35) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2726814 | 0.95 | TOP1 (0.35) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2724912 | 0.95 | CYP1A1 (0.35) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2724999 | 0.92 | CYP1A1 (0.33) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2726138 | 0.88 | CYP1A2 (0.39) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2726233 | 0.87 | CYP1A2 (0.35) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2727043 | 0.86 | L3MBTL1 (0.46) | MAOBALDH1A1KDM4EL3MBTL1LMNA | |
| SCHEMBL2724591 | 0.86 | FEN1 (0.36) | TOP1ALDH1A1KDM4EL3MBTL1LMNA | |
| SCHEMBL2726126 | 0.86 | CYP1A2 (0.38) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 | |
| SCHEMBL2713035 | 0.86 | CYP1A2 (0.41) | CYP1A1CYP1A2CYP1B1NOTUMHSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| EP-2445987-B1 | BLUE/VIOLET DIPHENYLANTHRACENE CHEMILUMINESCENT FLUORESCERS | CYALUME TECH INC (US) | 2018-05-02 | — | — | EP | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-8257620-B2 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. (US) | 2012-09-04 | — | — | US | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYALUME TECHNOLOGIES, INC. | 2010-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100327240-A1 | Blue/violet diphenylanthracene chemiluminescent fluorescers | CYP2F1, FLAD1, AFF1 | CYP1A1 5/4885CYP1A2 22/4885CYP1B1 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.